[{"path":"index.html","id":"summary","chapter":"1 Summary","heading":"1 Summary","text":"document provides guidance dosing administration low-dose ketamine adults uncontrolled complex acute pain.1 Low-dose ketamine initiated, prescribed, titrated discontinued acute pain consultant, anaesthetist specialist pain nurses. guideline cover administration ketamine anaesthetic agent relief procedural pain areas emergency department, chronic pain palliative care.","code":""},{"path":"introduction.html","id":"introduction","chapter":"2 Introduction","heading":"2 Introduction","text":"Acute pain common condition requires effective timely management alleviate suffering promote patient comfort, also prevent development chronic persistent pain1.patients thought greater risk developing persistent post-surgical pain example, amputations, multiple fractures polytrauma, can due uncontrolled pre post-operative pain nerve damage2. stress response, coupled nerve damage can lead wind-make controlling pain difficult3.opioids traditionally mainstay acute pain management, concerns regarding adverse effects, escalating opioid requirements potential dependence misuse, led search alternative analgesic strategies4.Ketamine anaesthetic agent, low doses can effective analgesic without inducing anaesthesia.\nFigure 2.1: Ketamine (phencyclidine derivative) N-methyl-D-aspartate receptor antagonists dissociative analgesic anesthetic.\nKetamine works blocking N-methyl D-asparate (NDMA) receptor, receptor responsible amplifying pain signals, development central sensitisation opioid tolerance. analgesic action occurs dorsal horn spinal cord, reducing action glutamate – major excitatory neurotransmitter.5\nFigure 2.2: Diagram NMDA Receptor Sites Ligand Attachment: NMDA receptor made four components, specifically two NR1 two NR2 subunits. external area, binding sites designed co-agonists glutamate glycine, essential effectively opening ion channel. channel contains binding locations blocking pore; one designated Mg2+ ions, accommodates substances like ketamine, MK-801, memantine, similar compounds.\n","code":""},{"path":"indications.html","id":"indications","chapter":"3 Indications","heading":"3 Indications","text":"Low-dose ketamine can initiated pain service patients responded conventional analgesia fall inclusion criteria belowEscalating total opioid dosing greater 60 mg morphine equivalents per dayEscalating total opioid dosing greater 60 mg morphine equivalents per dayComplex pain – pain responded strong opioids / pain caused complex pathophysiology, resulting mix nociceptive neuropathic painComplex pain – pain responded strong opioids / pain caused complex pathophysiology, resulting mix nociceptive neuropathic painNeuropathic pain – including phantom limb pain, traumatic injuriesNeuropathic pain – including phantom limb pain, traumatic injuriesPatients hyper analgesia – increased severity pain stimuli usually less painfulPatients hyper analgesia – increased severity pain stimuli usually less painfulPatients allodynia- pain caused stimuli, wouldn’t usually painfulPatients allodynia- pain caused stimuli, wouldn’t usually painfulPatients undergone several painful procedures – may taken opioids preceding injury surgeryPatients undergone several painful procedures – may taken opioids preceding injury surgery","code":""},{"path":"contraindications.html","id":"contraindications","chapter":"4 Contraindications","heading":"4 Contraindications","text":"contraindications absoluteAllergy ketamine (absolute)Allergy ketamine (absolute)Previous history ketamine abuse dependence; however, criterion serve exclusionary factor patient considerationPrevious history ketamine abuse dependence; however, criterion serve exclusionary factor patient considerationPregnancyPregnancySchizophreniform psychosisSchizophreniform psychosisCaution also taken patients may suffer following:Acute porphyriaAcute porphyriaRaised intracranial pressure (although evidence suggests ketamine may neuroprotective)Raised intracranial pressure (although evidence suggests ketamine may neuroprotective)Uncontrolled hypertensionUncontrolled hypertensionIschemic heart diseaseIschemic heart diseasePsychiatric conditionsPsychiatric conditionsConfusionConfusionEpilepsyEpilepsyKetamine metabolised liver; therefore, hepatic clearance required terminate effects ketamine. prolonged duration action (increased contex sensitive half-time) may occur patients cirrhosis types hepatic impairment, dose reductions considered patients. Ketamine undergoes renal excretion; however, requirement dose adjustment patients underlying renal dysfunction dose ranges suggested guideline.","code":""},{"path":"ketamine-infusions.html","id":"ketamine-infusions","chapter":"5 Ketamine infusions","heading":"5 Ketamine infusions","text":"IV ketamine infusions prescribed paper IV Ketamine infusion chart require two competent registered nurses sign administration (see appendix 1).Ketamine also schedule 2 controlled drug required stored controlled drugs locked cupboard. Patients low dose IV ketamine infusions must cared either HDU high observation area.ketamine strength used infusions 500mg/ 10ml, added 40ml NaCl 0.9% create standard concentration ketamine 10mg/ml. See appendix 2 guidance preparation infusion. infusion delivered via locked syringe driver drug line renewed every 24 hours.","code":""},{"path":"ketamine-infusions.html","id":"starting-dosages","chapter":"5 Ketamine infusions","heading":"5.1 Starting dosages:","text":"5mg/hr (0.5ml/hr) weight ≤ 50kg - can titrated 10mg/hr (1.0ml/hr)5mg/hr (0.5ml/hr) weight ≤ 50kg - can titrated 10mg/hr (1.0ml/hr)10mg/hr (1.0ml.hr) weight >50kg – can tritrated 20mg/hr (2.0ml/hr)10mg/hr (1.0ml.hr) weight >50kg – can tritrated 20mg/hr (2.0ml/hr)frail elderly consider initial dose 0.5ml/hr cautious dose titration.frail elderly consider initial dose 0.5ml/hr cautious dose titration.","code":""},{"path":"oral-ketamine.html","id":"oral-ketamine","chapter":"6 Oral ketamine","heading":"6 Oral ketamine","text":"possible, ketamine chosen administered orally, less risk error. Oral ketamine prescribed oral suspension (50mg/ 5ml) electronically, also schedule 2 controlled drug require two registered nurses administer drug EPMA. Oral ketamine can administered base medical surgical ward, requirement additional vital signs monitoring. treatment acute pain, low dose oral ketamine usually prescribed 72 hours, however pain service review patient daily dose frequency can titrated accordingly.\nStarting doses:\nUsually 25mg, 6 hourly however titrated pain service maximum 400mg per day (100mg, 6 hourly).","code":""},{"path":"monitoring.html","id":"monitoring","chapter":"7 Monitoring","heading":"7 Monitoring","text":"patient’s receiving oral ketamine, isn’t requirement additional monitoring vital signs. However, patient’s receiving low dose IV ketamine infusions require monitoring per table , documented onto prescription chart (see appendix 1)\nFigure 7.1: Suggested frequency patient’s observations recorded starting changing ketamine.\n","code":""},{"path":"side-effects.html","id":"side-effects","chapter":"8 Side effects","heading":"8 Side effects","text":"Research shown low doses ketamine, majority people experience either mild absence adverse effects. Unlike opioids, hypotension respiratory depression common side effects associated Ketamine, due positive inotropic effect, ability preserve respiratory drive. However, common side effects associated ketamine dysphoria hallucinations.","code":""},{"path":"side-effects.html","id":"sedation","chapter":"8 Side effects","heading":"8.1 Sedation","text":"sedation score 2 patient unarousable, stop ketamine infusion opioid medications, get immediate help administer oxygen therapy. Naloxone effect ketamine, however considered patient receiving concurrent opioids sedation score 2 /respiratory depression. sedation score 1, infusion rate reduced half. patient receiving oral ketamine, omit next dose request member pain service review dosage reassess analgesia.","code":""},{"path":"side-effects.html","id":"respiratory-depression","chapter":"8 Side effects","heading":"8.2 Respiratory Depression","text":"usually associated rapid IV bolus’s ketamine, however event, discontinue infusion respiratory rate 8 breaths/ minute. Discontinue concurrent opioids, administer oxygen therapy get immediate help.","code":""},{"path":"side-effects.html","id":"dysphoria-hallucinations-vivid-dreams","chapter":"8 Side effects","heading":"8.3 Dysphoria, Hallucinations, Vivid Dreams","text":"Ketamine can cause dissociative effect can lead dysphoria hallucinations, however sub-anaesthetic doses rare. event patient experiencing , please reassure patient, depending severity; either reduce rate half pause infusion one hour re assess. patient receiving oral ketamine, omit next dose request member pain service review dosage.","code":""},{"path":"stopping-low-dose-ketamine.html","id":"stopping-low-dose-ketamine","chapter":"9 Stopping Low-dose Ketamine","heading":"9 Stopping Low-dose Ketamine","text":"IV oral low-dose ketamine used short term managing acute pain, usually 72-96 hours. Patients receiving low dose ketamine reviewed daily acute pain team concerns escalated -call anaesthetist hours.\nKetamine can discontinued abruptly, ketamine addictive used short termly, cause physical mental withdrawal symptoms. However, can titrated ensure patient experience sudden return pain. also advisable discontinue strong opioids prior discontinuation ketamine, patient can experience rebound hyper anelgesia.","code":""},{"path":"references.html","id":"references","chapter":"10 References","heading":"10 References","text":"","code":""}]
